The neurotech startup, founded in 2025 by neuroscientist Hamed Bahmani and physician Selina Greuel, is developing a "brain-computer interface for the targeted modulation of brain activity involved in regulating mood and stress."
Insellar has raised €400k across 1 funding round from 1 investor, most recently a round in Apr 2026. Based in Berlin, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-16 | Other | €400k |
| IBB Ventures |
| View deal → |
